Table 1 Baseline characteristics of patients without neuropathic pain and with neuropathic pain
Variable | NEP- (N = 48) | NEP+ (N = 44) | P-value* |
|---|---|---|---|
Number of women, (%) | 41 (85) | 25 (57) | 0.002 |
Age group, years, N (%) | 0.87 | ||
75 | 30 (62) | 29 (66) | |
80 | 12 (25) | 11 (25) | |
85 | 6 (13) | 4 (9) | |
Living alone, N (%) | 25 (53) | 18 (41) | 0.24 |
Duration of pain, years, (%) | 0.72 | ||
< 1 | 8 (17) | 8 (18) | |
1–2 | 15 (31) | 10 (23) | |
≥ 3 | 25 (52) | 26 (59) | |
MMSE, mean (SD) | 28 (2) | 27 (2) | 0.44 |
Subjective health, N (%) | 0.97 | ||
Good | 17 (37) | 16 (36) | |
Satisfactory | 21 (46) | 21 (48) | |
Insufficient | 8 (17) | 7 (16) | |
Subjective moving capability, n (%) | 0.76 | ||
Good | 16 (33) | 15 (34) | |
Satisfactory | 18 (38) | 19 (43) | |
Insufficient | 14 (29) | 10 (23) | |
Comorbidities | |||
Cardiovascular diseases | 35 (73) | 29 (66) | 0.47 |
Musculoskeletal diseases | 31 (65) | 21 (48) | 0.10 |
Endocrine diseases | 22 (46) | 18 (41) | 0.63 |
Respiratory diseases | 13 (27) | 8 (18) | 0.31 |
Neoplasms | 6 (13) | 4 (9) | 0.60 |
Psychiatric diseases | 2 (4) | 0 (0) | 0.49 |
Nervous system diseases | 1 (2) | 3 (7) | 0.35 |
BAI, mean (SD) | 12.6 (8.1) | 13.5 (11.6) | 0.68 |
GDS-15, mean (SD) | 3.04 (2.50) | 3.84 (3.02) | 0.18 |
SF-36, mean (SD) | |||
Physical Component Summary | 34 (12) | 33 (11) | 0.63 |
Mental Component Summary | 53 (10) | 52 (11) | 0.57 |
Pain medication, N (%) | 36 (75) | 36 (82) | 0.43 |
Paracetamol | 29 (60) | 24 (55) | 0.57 |
NSAID (peroral) | 14 (29) | 19 (43) | 0.16 |
NSAID (topical) | 8 (17) | 2 (5) | 0.093 |
Mild opioid | 5 (10) | 7 (16) | 0.54 |
Neuropathic pain druga | 3 (6) | 4 (9) | 0.71 |